Patent ID: 9549960
Date: 2017-01-24
CPC Classifications: A61K,A61M

Claim:
1. A method of supplying a therapeutic agent locally to a tissue wound site of a patient, said method comprising the steps of: a) applying a blend of a carrier and a treatment agent transdermally to said tissue wound site to heal said wound site; and b) testing urine of said patient having said damaged tissue for an increase of yellow color to verify, or determine the extent of, transdermal penetration of the blend at the tissue wound site; wherein said carrier comprises methyl nicotinate for delivering energy to said wound site and for facilitating gene repair and beta-alanine for accelerating an anti-inflammatory response; wherein said blend comprises active ingredients that enable healing by accelerating tissue growth and that stimulate the immune system to heal the damaged tissue; wherein said active ingredients for wound healing comprise said methyl nicotinate, arachidonic acid, hypoxanthine riboside, histadine, said beta-alanine, glycine, taurine, pyridoxal-5-phosphate, trace minerals including copper, optionally histamine and optionally imidazole acetic acid; wherein said hypoxanthine riboside acts as a precursor of cellular energy and, together with said methyl nicotinate, said pyridoxal-5-phosphate, and said copper, facilitates methylation and redox up-regulation; wherein said glycine and said beta-alanine are included in said blend, in part, for activation of ribosome switches to speed up healing of said damaged tissue; wherein said blend also contains at least one member selected from the group consisting of glycerol, polysorbate 20, and propylene glycol to promote transdermal penetration; and wherein said blend further comprises riboflavin, said riboflavin providing an indicator of the effectiveness of the topical absorption of the blend.